VERU INC. Interest Expense
VERU INC. (VERU) reported Interest Expense of $145.31 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-08
- VERU INC. interest expense for the quarter ending 2024-03-31 was $145.31K, a 79.17% decline year-over-year.
- VERU INC. interest expense for the quarter ending 2023-12-31 was $164.96K, a 81.11% decline year-over-year.
- VERU INC. interest expense for the quarter ending 2023-09-30 was $207.20K, a 74.49% decline year-over-year.
- VERU INC. interest expense for the quarter ending 2023-06-30 was $648.92K, a 45.24% decline year-over-year.
- VERU INC. interest expense for fiscal 2023 was $2.43M, a 44.45% decline from fiscal 2022.
- VERU INC. interest expense for fiscal 2022 was $4.37M, a 10.59% decline from fiscal 2021.
- VERU INC. interest expense for fiscal 2021 was $4.89M, a 5.73% increase from fiscal 2020.
- VERU INC. interest expense for fiscal 2020 was $4.62M, a 1.80% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $145.31K 10-Q · filed 2024-05-08 | $310.27K 10-Q · filed 2024-05-08 | $517.47K derived: sum of 3 quarters · filed 2024-05-08 | $1.17M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | $164.96K 10-Q · filed 2024-04-01 | $372.16K derived: sum of 2 quarters · filed 2024-04-01 | $1.02M derived: sum of 3 quarters · filed 2024-04-01 | $1.72M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-09-30 | $207.20K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $856.12K derived: sum of 2 quarters · filed 2024-04-01 | $1.55M derived: sum of 3 quarters · filed 2024-05-08 | $2.43M 10-K/A · filed 2024-04-01 |
| 2023-06-30 | $648.92K 10-Q/A · filed 2023-11-15 | $1.35M derived: sum of 2 quarters · filed 2024-05-08 | $2.22M 10-Q/A · filed 2023-11-15 | $3.03M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $697.69K 10-Q · filed 2024-05-08 | $1.57M 10-Q · filed 2024-05-08 | $2.38M derived: sum of 3 quarters · filed 2024-05-08 | $3.57M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $873.23K 10-Q · filed 2024-04-01 | $1.69M derived: sum of 2 quarters · filed 2024-04-01 | $2.87M derived: sum of 3 quarters · filed 2024-04-01 | $4.08M derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-09-30 | $812.32K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $2.00M derived: sum of 2 quarters · filed 2024-04-01 | $3.21M derived: sum of 3 quarters · filed 2024-04-01 | $4.37M 10-K/A · filed 2024-04-01 |
| 2022-06-30 | $1.19M 10-Q/A · filed 2023-11-15 | $2.40M derived: sum of 2 quarters · filed 2023-11-15 | $3.56M 10-Q/A · filed 2023-11-15 | $4.71M derived: sum of 4 quarters · filed 2023-11-15 |
| 2022-03-31 | $1.21M 10-Q · filed 2023-05-11 | $2.37M 10-Q · filed 2023-05-11 | $3.53M derived: sum of 3 quarters · filed 2023-05-11 | $4.82M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.16M 10-Q · filed 2023-02-09 | $2.32M derived: sum of 2 quarters · filed 2023-02-09 | $3.60M derived: sum of 3 quarters · filed 2023-02-09 | $4.86M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $2.45M derived: sum of 2 quarters · filed 2022-12-05 | $3.70M derived: sum of 3 quarters · filed 2022-12-05 | $4.89M 10-K · filed 2022-12-05 |
| 2021-06-30 | $1.29M 10-Q · filed 2022-08-11 | $2.54M derived: sum of 2 quarters · filed 2022-08-11 | $3.73M 10-Q · filed 2022-08-11 | $4.87M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-12 | $2.44M 10-Q · filed 2022-05-12 | $3.59M derived: sum of 3 quarters · filed 2022-05-12 | $4.76M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.19M 10-Q · filed 2022-02-09 | $2.33M derived: sum of 2 quarters · filed 2022-02-09 | $3.50M derived: sum of 3 quarters · filed 2022-02-09 | $4.67M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $2.32M derived: sum of 2 quarters · filed 2021-12-02 | $3.48M derived: sum of 3 quarters · filed 2021-12-02 | $4.62M 10-K · filed 2021-12-02 |
| 2020-06-30 | $1.17M 10-Q · filed 2021-08-12 | $2.33M derived: sum of 2 quarters · filed 2021-08-12 | $3.48M 10-Q · filed 2021-08-12 | $4.55M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $1.16M 10-Q · filed 2021-05-12 | $2.31M 10-Q · filed 2021-05-12 | $3.38M derived: sum of 3 quarters · filed 2021-05-12 | $4.48M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $1.14M 10-Q · filed 2021-02-10 | $2.22M derived: sum of 2 quarters · filed 2021-02-10 | $3.31M derived: sum of 3 quarters · filed 2021-02-10 | $4.57M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-09-30 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $2.17M derived: sum of 2 quarters · filed 2020-12-10 | $3.43M derived: sum of 3 quarters · filed 2020-12-10 | $4.71M 10-K · filed 2020-12-10 |
| 2019-06-30 | $1.09M 10-Q · filed 2020-08-13 | $2.35M derived: sum of 2 quarters · filed 2020-08-13 | $3.63M 10-Q · filed 2020-08-13 | $4.85M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $1.26M 10-Q · filed 2020-05-13 | $2.54M 10-Q · filed 2020-05-13 | $3.76M derived: sum of 3 quarters · filed 2020-05-13 | $5.14M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $1.28M 10-Q · filed 2020-02-12 | $2.50M derived: sum of 2 quarters · filed 2020-02-12 | $3.88M derived: sum of 3 quarters · filed 2020-02-12 | $4.23M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-09-30 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $2.60M derived: sum of 2 quarters · filed 2019-12-12 | $2.95M derived: sum of 3 quarters · filed 2019-12-12 | $2.95M 10-K · filed 2019-12-12 |
| 2018-06-30 | $1.38M 10-Q · filed 2019-08-08 | $1.73M derived: sum of 2 quarters · filed 2019-08-08 | $1.73M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $350.60K 10-Q · filed 2019-05-15 | $350.60K 10-Q · filed 2019-05-15 | ||
| 2015-06-30 | $1.94K 10-Q · filed 2015-07-30 | $5.13K 10-Q · filed 2015-07-30 | ||
| 2014-06-30 | $993.00 10-Q · filed 2015-07-30 | -$106.00K 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |